Oncology

SCRC manages to provide high quality clinical trials by relying on specialized professionals, experts, key opinion leaders and patients who contribute together to find new solutions to fight cancer. Our expertise covers mainly drug classes like hormonal therapies, cytokines, cytotoxics, cytostatics, hematopoietic growth factors and supportive care, but we also benefit from a first-rate experience with more recent anti-cancer drugs such as small molecule tyrosine kinase inhibitors, monoclonal antibodies, anti-cancer vaccines, anti-angiogenics, new delivery systems and several other targeted therapies.